22nd Century Group, Inc. (XXII)
NASDAQ: XXII · Real-Time Price · USD
8.72
-1.40 (-13.83%)
At close: Jun 20, 2025, 4:00 PM
8.30
-0.42 (-4.82%)
After-hours: Jun 20, 2025, 6:49 PM EDT

Company Description

22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States.

The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products.

It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands.

22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.

22nd Century Group, Inc.
22nd Century Group logo
Country United States
Founded 1998
Industry Tobacco
Sector Consumer Staples
Employees 56
CEO Lawrence Firestone

Contact Details

Address:
321 Farmington Road
Mocksville, North Carolina 27028
United States
Phone (336) 940-3769
Website xxiicentury.com

Stock Details

Ticker Symbol XXII
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001347858
CUSIP Number 90137F400
ISIN Number US90137F4000
Employer ID 98-0468420
SIC Code 2111

Key Executives

Name Position
Lawrence D. Firestone President, Chief Executive Officer and Chairman
Daniel A. Otto Chief Financial Officer and Principal Accounting Officer
Jonathan Staffeldt General Counsel and Secretary
Robert P. Manfredonia Executive Vice President of Sales and Marketing
Matthew Kreps Investor Relations
James C. Morrison Technical Advisor and Regulatory Affairs Consultant

Latest SEC Filings

Date Type Title
Jun 20, 2025 S-3 Registration statement under Securities Act of 1933
Jun 16, 2025 8-K Current Report
Jun 10, 2025 DEF 14A Other definitive proxy statements
Jun 10, 2025 PRER14A Filing
Jun 6, 2025 PRER14A Filing
May 28, 2025 SCHEDULE 13G Filing
May 22, 2025 EFFECT Notice of Effectiveness
May 22, 2025 PRE 14A Other preliminary proxy statements
May 22, 2025 8-K Current Report
May 22, 2025 424B3 Prospectus